Cencora, Inc. (NYSE:COR) Given Consensus Rating of "Moderate Buy" by Analysts

Cencora, Inc. (NYSE:COR - Get Free Report) has been assigned an average rating of "Moderate Buy" from the eleven research firms that are covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $271.20.

A number of research firms have recently weighed in on COR. Barclays lifted their price target on shares of Cencora from $263.00 to $290.00 and gave the company an "overweight" rating in a research report on Thursday, November 7th. StockNews.com downgraded shares of Cencora from a "strong-buy" rating to a "buy" rating in a research report on Friday, September 20th. Leerink Partners lowered their price objective on shares of Cencora from $277.00 to $275.00 and set an "outperform" rating for the company in a research report on Monday, October 7th. JPMorgan Chase & Co. boosted their price objective on shares of Cencora from $280.00 to $287.00 and gave the company an "overweight" rating in a research report on Wednesday, August 21st. Finally, UBS Group boosted their price objective on shares of Cencora from $275.00 to $285.00 and gave the company a "buy" rating in a research report on Thursday, November 7th.

Cencora Price Performance

Shares of NYSE COR traded down $0.18 during midday trading on Monday, reaching $244.84. The company's stock had a trading volume of 379,283 shares, compared to its average volume of 1,395,667. The company has a debt-to-equity ratio of 4.84, a quick ratio of 0.53 and a current ratio of 0.88. Cencora has a fifty-two week low of $195.83 and a fifty-two week high of $251.56. The business's 50 day moving average price is $233.22 and its two-hundred day moving average price is $231.70. The company has a market cap of $48.25 billion, a P/E ratio of 32.63, a P/E/G ratio of 1.63 and a beta of 0.44.

Cencora Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 29th. Stockholders of record on Friday, November 15th will be issued a dividend of $0.55 per share. The ex-dividend date of this dividend is Friday, November 15th. This is an increase from Cencora's previous quarterly dividend of $0.51. This represents a $2.20 annualized dividend and a dividend yield of 0.90%. Cencora's dividend payout ratio is 29.29%.

Insider Transactions at Cencora

In related news, Chairman Steven H. Collis sold 21,509 shares of the business's stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $235.80, for a total value of $5,071,822.20. Following the sale, the chairman now owns 285,088 shares of the company's stock, valued at $67,223,750.40. The trade was a 7.02 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 15.80% of the company's stock.

Institutional Trading of Cencora

Several institutional investors have recently modified their holdings of the business. Lake Street Advisors Group LLC grew its stake in shares of Cencora by 1.3% in the third quarter. Lake Street Advisors Group LLC now owns 3,415 shares of the company's stock worth $769,000 after purchasing an additional 43 shares during the last quarter. Financial Advocates Investment Management boosted its position in Cencora by 4.7% during the second quarter. Financial Advocates Investment Management now owns 978 shares of the company's stock valued at $220,000 after acquiring an additional 44 shares during the last quarter. Venturi Wealth Management LLC boosted its position in Cencora by 1.0% during the third quarter. Venturi Wealth Management LLC now owns 4,447 shares of the company's stock valued at $1,001,000 after acquiring an additional 46 shares during the last quarter. Prime Capital Investment Advisors LLC boosted its position in Cencora by 1.2% during the third quarter. Prime Capital Investment Advisors LLC now owns 3,768 shares of the company's stock valued at $848,000 after acquiring an additional 46 shares during the last quarter. Finally, Checchi Capital Advisers LLC boosted its position in Cencora by 2.2% during the second quarter. Checchi Capital Advisers LLC now owns 2,217 shares of the company's stock valued at $499,000 after acquiring an additional 48 shares during the last quarter. Institutional investors own 97.52% of the company's stock.

About Cencora

Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.